Literature DB >> 22892442

Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: a peripheral quantitative computed tomography (pQCT) study.

Agostino Gaudio1, Piera Pennisi, Francesco Muratore, Gaetano Bertino, Annalisa Ardiri, Ivana Pulvirenti, Giovanni Tringali, Carmelo Erio Fiore.   

Abstract

BACKGROUND: The prevalence of osteoporosis in chronic liver disease (CLD) varies considerably among the studies, depending on patient selection and diagnostic criteria. We aimed to measure bone turnover markers and volumetric bone mineral density (BMD) in a group of postmenopausal women with CLD using both dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT), in comparison with age-matched healthy subjects.
METHODS: Thirty-five postmenopausal patients with HCV-correlated CLD and 35 healthy postmenopausal women, as controls, underwent a DXA scan at lumbar and femoral level and a pQCT measurement of the nondominant forearm. Serum concentrations of biochemical markers relevant to bone turnover were also measured.
RESULTS: Patients showed no differences in DXA values either at lumbar or femoral level compared to controls. On the contrary, pQCT geometrical (cortical cross-sectional area) and volumetric (total and trabecular volumetric BMD) parameters were significantly reduced in the CLD women. Also the Strength-Strain Index (SSI), an estimate of diaphyseal bone resistance to bending and torsion, was significantly lower in patients than in controls. Patients with CLD presented an unbalanced bone turnover, with increased bone resorption markers.
CONCLUSIONS: The bone geometrical and volumetric parameters measured in our CLD postmenopausal women, by pQCT, show a reduced bone mineral quality and stiffness. Conversely, DXA-measurements seem unable to appreciate the bone alterations in these patients. This would encourage further studies to validate pQCT analysis as a diagnostic tool for a correct estimate of bone involvement in CLD.
Copyright © 2012 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22892442     DOI: 10.1016/j.ejim.2012.05.011

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  7 in total

Review 1.  Bone health in HIV and hepatitis B or C infections.

Authors:  Emmanuel Biver; Alexandra Calmy; René Rizzoli
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-10-07       Impact factor: 5.346

2.  Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008-2010 Korea National Health and Nutrition Examination Surveys.

Authors:  Myong Ki Baeg; Seung Kew Yoon; Sun-Hye Ko; Kyung-Do Han; Hye Jin Choi; Si Hyun Bae; Jong Young Choi; Myung-Gyu Choi
Journal:  Hepatol Int       Date:  2016-02-05       Impact factor: 6.047

3.  Decreased bone cortical density at the forearm in subjects with subclinical peripheral arterial disease.

Authors:  A Gaudio; F Muratore; V Fiore; R Rapisarda; S S Signorelli; C E Fiore
Journal:  Osteoporos Int       Date:  2015-02-12       Impact factor: 4.507

4.  Crosssectional Assessment of Bone Mass Density in Adults with Hepatitis B Virus and Hepatitis C Virus Infection.

Authors:  Yuan-Yuei Chen; Wen-Hui Fang; Chung-Ching Wang; Tung-Wei Kao; Yaw-Wen Chang; Hui-Fang Yang; Chen-Jung Wu; Yu-Shan Sun; Wei-Liang Chen
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

5.  Association between hepatitis C virus infection and osteoporotic fracture risk among postmenopausal women: a cross-sectional investigation in Taiwan.

Authors:  Ming-Shyan Lin; Po-Han Chen; Po-Chang Wang; Huang-Shen Lin; Tung-Jung Huang; Shih-Tai Chang; Wen-Nan Chiu; Mei-Yen Chen
Journal:  BMJ Open       Date:  2019-01-15       Impact factor: 2.692

6.  Early vascular ageing biomarkers in osteoporotic outpatients: a pilot study.

Authors:  Agostino Gaudio; Anastasia Xourafa; Luca Zanoli; Rosario Rapisarda; Antonino Catalano; Salvatore Santo Signorelli; Pietro Castellino
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

7.  Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine.

Authors:  Hila Haskelberg; Nicholas Pocock; Janaki Amin; Peter Robert Ebeling; Sean Emery; Andrew Carr; Anthony Allworth
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.